The IL-22–/– mice still developed more severe colitis upon DSS treatment than the wildtype mice when co-housed, and therefore both the lack of IL-22 function in the host, as well as the (‘transmissible’) microbiota of these mice play a role in the severity of DSS-induced colitis. Here, IL22 is linked to colitis.